However, SOD1G93A mice made deficient for NF-κB activation in astrocytes do not show an ameliorated ALS phenotype despite a slight but significant reduction in astrogliosis at onset. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.